Imaging characteristics of gastrointestinal foreign bodies in children and analysis of risk factors associated with the severity of complications - Scorecard - MDSpire

Imaging characteristics of gastrointestinal foreign bodies in children and analysis of risk factors associated with the severity of complications

  • By

  • Hongzhi Du

  • Liling Shi

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Imaging Features of Gastrointestinal Foreign Bodies in Pediatric Patients and Examination of Complication Severity Risk Factors

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPediatric patients under 12 years old, primarily those aged 1-3 years, as they are the most affected group.
Care Setting

Key Highlights

  • surgery

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • d
      • d
      • r
      • e
      • c
      • o
      • m
      • m
      • e
      • n
      • d
      • a
      • t
      • i
      • o
      • n
      • f
      • o
      • r
      • i
      • m
      • a
      • g
      • i
      • n
      • g
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • i
      • n
      • h
      • i
      • g
      • h
      • -
      • r
      • i
      • s
      • k
      • c
      • a
      • s
      • e
      • s
      • .

      Risks

        Patient & Prescribing Data

        Include endoscopy and observation as treatment options.

        Clinical Best Practices

        • practices

        Related Resources & Content

        Original Source(s)

        Imaging characteristics of gastrointestinal foreign bodies in children and analysis of risk factors associated with the severity of complications

        • by Hongzhi Du, Liling Shi

        • June 15, 2026

        Related Content

        Editorial: Understanding oral health challenges in pediatric and adult cancer care

        When Bad Data Enters the Drug Pipeline

        Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

        FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

        The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.